Vivo Capital Fund VIII, L.P., 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), bought 859,950 shares at $20.73 ($9.8M) on 2018-07-20, disclosed to the SEC on 2018-07-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 353,590 | $0 | 0.0% |
| 2 | $17.00 | 7,137 | $121K | 1.2% |
| 3 | $17.00 | 51,686 | $879K | 9.0% |
| 4 | $17.00 | 141,177 | $2.4M | 24.6% |
| 5 | $20.73 | 153,180 | $3.2M | 32.6% |
| 6 | $20.73 | 153,180 |
| $3.2M |
| 32.6% |
| Total | $11.34 avg | 859,950 | $9.8M | 100% |
| Filing → |
| CRNX | SELL | 2020-02-06 | $606K | — | Filing → |
| MNLO | BUY | 2018-01-29 | $5.0M | — | Filing → |
| BPMX | BUY | 2017-05-01 | $2.0M | — | Filing → |